A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions

Breast CancerSolid Tumor

Interventions

DRUG

GNC-077

Administration by intravenous infusion for a cycle of 3 weeks.

Trial Locations (1)

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY